Trial Profile
A Site and Subject Blinded Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS 852927 in Patients With Primary Hypercholesterolemia on a Stable Dose of Statin Therapy
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2013
Price :
$35
*
At a glance
- Drugs BMS 852927 (Primary) ; HMG-CoA reductase inhibitors
- Indications Hypercholesterolaemia
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2013 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov record.
- 01 Aug 2012 New trial record